Healthcare products and solutions brand, 2San, has launched a dual kit for SARS-CoV-2 & Influenza A+B. With the ongoing demand set upon the NHS post pandemic, the over-the-counter kit has been launched to help alleviate pressures on healthcare institutions.
The single use test kit takes ten minutes to detect the SARS-CoV-2, Influenza A and Influenza B viruses that cause COVID-19 and Influenza, giving people the option to test from home and to obtain a fast and accurate diagnosis.
2San says this diagnostic is indicative of the organisation’s continual investment in innovation and development of healthcare products to improve public health.
Recent research from 2San revealed that 86% of people surveyed used lateral flow tests during the pandemic, with 87% saying using them gave them reassurance of their health status.
Mark Hewlett, global CEO at 2San said: “This test is revolutionary in that it will allow people to determine the appropriate treatment pathway to take. it will alleviate pressure on primary healthcare institutions, and it will also avoid inadvertent medical use of therapeutics or drugs that aren’t necessary.
“The dual test will be affordable and accessible, allowing environments like schools and workplaces to be safer and healthier places.
“2San’s mission is ‘Better Care Better Life’ and we feel the news of our launch of this dual test perfectly aligns with that vision.”
